DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Keating GM.
Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin’s lymphoma.
Target Oncol 2015;
10(1): 141-151
We do not assume any responsibility for the contents of the web pages of other providers.